GSK global boss to meet stakeholders in Ulverston plant
TOMMORROW (13) the GSK plant in Ulverston will play host to a meeting between key stakeholders and the company's president of global manufacturing.
The meeting could provide fresh answers for a task force set up in the wake of GSK's announcement it was no longer investing in the area. A proposed £350m plan to enhance the company's cephalosporins business was ditched earlier this year. A review of the site is currently under way and the most likely outcome of that will be the sale of the plant.
Roger Conner, president of global manufacturing and supply, will meet with local MP John Woodcock as well as members of South Lakeland District Council, the Cumbria Local Enterprise Partnership and other important figures in the area.
Pat McIver, biopharm lead at the Ulverston site, said: "Roger is coming for a routine visit to the site. He comes once or twice a year to the site to see how we are doing and to talk about business matters and production.
"We're taking an opportunity to meet with a few local stakeholders when he is here."
SLDC councillor Graham Vincent, portfolio holder for economy and assets, said securing a viable future for the site was essential.
He said: "I would look for the assurance that the business is marketable and is at its very best. What investment needs to be made to make it as attractive as possible to a buyer."
The Mail approached Barrow and Furness MP John Woodcock for his views about the meeting but he declined to comment.